Skip to content
AnalystLens

Lam ResearchLRCX

Legal name
Lam Research Corporation
Industry
Special Industry Machinery, NEC
Exchange
Nasdaq

Stock Price $LRCX

You are here#13 of 103 in Technology by market cap

Filing record · 2016–202610-K1110-Q338-K129

LRCX filed 11 annual reports (10-K), 33 quarterly reports (10-Q) and 129 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · Oct ’16Oct ’16
  2. FY2019 annual report10-K · Aug ’19Aug ’19
  3. Leadership change8-K · Nov ’21Nov ’21
  4. Leadership change8-K · Nov ’25Nov ’25
Source: 10-KFY2026
Source: 10-KFY2026
Source: 10-KFY2026
Source: 10-KFY2026

Revenue Trend

Year-over-year comparison from 10-K annual reports

  1. $23.23B
YoY changeLargest recent move+45.6%in FY21Latest +26.0%

2 older moves run past ±50% (largest +91.2%); point at, tap or drag across the bars to read one.

Latest bar from 10-KFY2026Click a bar to open its SEC filing

View full history →

Lam Research Financial Overview 2022–2026

Updated Nov 3, 2026

Lam Research's share price rose from $97.20 at the close of FY2025 to $379.09a at the close of FY2026, a gain of roughly 290%. Earnings per share rose only 39%, from $4.15 to $5.76. The gap is the story: the market paid 23.4x earnings at the end of FY2025 and 65.8x at the end of FY2026, lifting market cap from $123.3B to $474.3B. The business is accelerating, but the multiple now carries much of the weight.

The operating record backs the optimism. Revenue grew from $17.2 billion in FY2022 to $23.23 billionb in FY2026, with a dip to $14.9 billion in FY2024 along the way. FY2026 revenue rose 26.0%, and net income climbed 35.6% to $7.27 billion. Gross margin widened from 45.7% in FY2022 to 50.5%, so each sales dollar now keeps about five cents more than it did four years earlier.

Spending and payouts kept pace. R&D reached $2.38 billionc in FY2026, up 13.3%. Lam spent $3.85 billion on buybacks and paid $1.27 billion in dividends, and ended the year with $5.60 billion in cash. China still supplied 34% of revenue, a concentration that carries trade risk. At 65.8x, the FY2026 close priced in continued growth, and the Q1 FY2027 revenue of $8.22 billion shows the growth has not stalled.

Recent Developments (Q4 2026 and Q1 2027)

Lam's growth accelerated across both quarters. Revenue reached $6.72 billiond in Q4 FY2026, up 15.1% sequentially. It then rose another 22% in Q1 FY2027. GAAP operating margin widened from 37.4% to 40.0% over the period, and gross margin reached 52.3%. Diluted EPS of $2.19 compares with $1.24 a year earlier. Systems revenue grew 62% year over year, and AI-driven demand was cited as the main driver. Separately, directors Sohail Ahmed and Michael Cannon retire on November 2, 2026, shrinking the board from 12 to 10.

Bull case: guidance of $8.20 billion to $9.00 billione for Q2 FY2027 points to further growth at rising margins. Bear case: Q4 FY2026 operating cash flow fell to $1.46 billion from $2.55 billion as receivables hit $5.34 billion. At 40.0x earnings as of October 21, 2026 (close of $230.15), the stock is priced for sustained growth.

What to watch: cash conversion as receivables and inventory build; whether revenue lands in the $8.20 billion to $9.00 billion guided range

Recent SEC Filings

  1. 8-KLam Research 8-K Report, Shareholder Vote Results (Nov 5, 2026)Lam Research Corporation (LRCX) filed an 8-K on November 5, 2026, primarily detailing the outcomes of its Annual Stockholders' Meeting and announcing significant capital allocation initiatives. The meeting, held on November 3, 2026, saw all director nominees elected with strong support, indicating shareholder confidence in the board. Key proposals, including advisory approval of executive compensation and ratification of KPMG LLP as the independent auditor for fiscal year 2027, also received overwhelming approval. However, a shareholder proposal seeking the right to call a special meeting did not pass, failing to gain majority support. Beyond the meeting results, the company announced a substantial $25 billion share repurchase authorization and declared a quarterly dividend of $0.33 per share. This strategic move underscores Lam Research's commitment to returning value to shareholders and reflects confidence in its financial position and future cash generation capabilities, as stated by CFO Doug Bettinger. The press release accompanying these announcements highlights the company's strong positioning in key technology inflections within the semiconductor industry.
  2. 8-KLam Research 8-K Report, Financial Results (Oct 21, 2026)Lam Research Corporation reported robust financial results for the fiscal quarter ended September 27, 2026, showcasing significant year-over-year and quarter-over-quarter growth. The company achieved record revenue of $8.22 billion, a substantial increase driven by strong demand for its semiconductor manufacturing equipment, particularly influenced by the AI sector. This top-line growth translated into impressive profitability, with both U.S. GAAP and non-GAAP diluted Earnings Per Share (EPS) showing a 21% increase compared to the previous quarter. Key operational improvements and strategic investments in technology and manufacturing capacity were highlighted as contributing factors to this performance. The company also demonstrated strong cash generation, with cash, cash equivalents, and restricted cash increasing significantly. Lam Research provided an optimistic outlook for the next quarter, projecting continued revenue growth and stable to improved margins, underscoring the company's favorable position in the expanding semiconductor equipment market, fueled by AI advancements.
  3. 8-KLam Research 8-K Report, Executive Changes (Aug 27, 2026)Lam Research Corporation (LRCX) announced on August 27, 2026, that two long-serving board members, Sohail U. Ahmed and Michael R. Cannon, have decided to retire. Their retirements will be effective on November 2, 2026. This departure will result in a reduction of the Board of Directors' size from 12 to 10 members. Both Mr. Ahmed and Mr. Cannon have made significant contributions during their tenures. Mr. Ahmed served for approximately seven years, participating in key committees like Audit, Compensation & Human Resources, and Innovation & Technology. Mr. Cannon, with a tenure of approximately 16 years, has a substantial record, including extensive service on the Audit, Compensation & Human Resources, and Nominating & Governance committees, where he also served as Chair for seven years. The company expressed its gratitude for their dedicated service and guidance.
  4. 8-KLam Research 8-K Report, Financial Results (Jul 29, 2026)Lam Research (LRCX) reported fiscal June 2026 quarter results on July 29, 2026 that were record-setting on revenue, operating margin, and EPS, driven by AI-related demand for leading-edge wafer fabrication equipment. Revenue rose 15.1% sequentially to $6.72 billion (up about 30% from $5.17 billion a year earlier), with U.S. GAAP gross margin of 51.7%, operating margin of 37.4%, and diluted EPS of $1.81. Non-GAAP diluted EPS was $1.82, reflecting modest adjustments for intangible amortization, elective deferred compensation valuation changes, and workforce optimization charges. Net income was $2.28 billion, and margins expanded roughly 190 to 240 basis points sequentially on both a GAAP and non-GAAP basis. Balance sheet and cash flow strengthened. Cash and equivalents rose to $5.58 billion from $4.75 billion, and operating cash flow was $1.46 billion for the quarter, though this was well below the prior-year quarter's $2.55 billion because of a large working capital build. Accounts receivable jumped to $5.34 billion from $4.13 billion, and inventories rose to $4.28 billion. Deferred revenue increased to $2.43 billion. Shareholder returns continued, with $247 million in buybacks and $325 million in dividends during the quarter, and the company declared a $0.26 per-share quarterly dividend. Management guided September 2026 quarter revenue to $8.10 billion (plus or minus $400 million), non-GAAP gross margin to 52.0% (plus or minus 1%), non-GAAP operating margin to 39.5% (plus or minus 1%), and non-GAAP diluted EPS to $2.15 (plus or minus $0.15) on 1.255 billion diluted shares. Investors should weigh the strong growth and margin trajectory against the rising receivables and working capital intensity, as well as exposure to concentrated customer geographies (Taiwan 27%, China 26%, Korea 20%) and ongoing export control and geopolitical risks.
  5. 8-KLam Research 8-K Report, Financial Results (Apr 22, 2026)Lam Research (LRCX) reported fiscal Q3 2026 results (quarter ended March 29, 2026) that set company records for revenue and EPS. Revenue rose 9% sequentially to $5.84 billion (up roughly 24% from $4.72 billion a year earlier), with U.S. GAAP operating margin expanding 110 basis points to 35.0% and U.S. GAAP diluted EPS climbing 15% to $1.45 (non-GAAP $1.47). Management attributed the strength to AI-driven demand for leading-edge wafer fabrication equipment, with systems revenue up about 11% sequentially and customer support revenue up about 6%. Cash-flow and balance-sheet items warrant attention. Cash, equivalents and restricted cash fell to $4.77 billion from $6.20 billion, driven by $1.16 billion of share repurchases, $751 million of debt principal payments (including the repayment of a current debt maturity), $325 million of dividends and $332 million of capex. Operating cash flow was still a solid $1.14 billion, though working capital absorbed $875 million, largely from a $636 million increase in receivables. Japan-related shipments awaiting customer acceptance rose to about $434 million of future revenue, up from $226 million. Guidance for the June 2026 quarter calls for revenue of $6.60 billion (plus or minus $400 million), U.S. GAAP gross margin of 50.5% and operating margin of 36.5% (each plus or minus 1 point), and diluted EPS of $1.65 (plus or minus $0.15) on 1.255 billion diluted shares. If delivered, this would imply further sequential revenue growth of roughly 13%. Investors should weigh the strength of the guidance against the sharp rise in receivables and the continued reliance on China (34% of revenue) and Korea and Taiwan (23% each) amid export-control and geopolitical risk.
View all 8-K filings →